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Early stationary phase culture supernatants of Strep-
tomyces coelicolor A3(2) contained at least four small
diffusible signaling molecules that could elicit preco-
cious antibiotic synthesis in the producing strain. The
compounds were not detected in exponentially growing
cultures. One of these compounds, SCB1, was purified to
homogeneity and shown to be a g-butyrolactone of
structure (2R,3R,1*R)-2-(1*-hydroxy-6-methylheptyl)-3-
hydroxymethylbutanolide. Bioassays of chemically syn-
thesized SCB1, and of its purified stereoisomers, suggest
that SCB1 acts in a highly specific manner to elicit the
production of both actinorhodin and undecylprodigio-
sin, the two pigmented antibiotics made by S. coelicolor.
Small diffusible signaling molecules play regulatory roles in
a wide variety of bacteria. The most intensively studied are the
N-acyl homoserine lactones, which have diverse roles as sig-
naling molecules in a wide range of Gram-negative bacteria (1).
Among Gram-positive bacteria, structurally similar but chem-
ically distinct g-butyrolactones play determining roles in anti-
biotic production and sporulation in Streptomyces species (2)
(Fig. 1). Streptomycetes are mycelial soil bacteria with a devel-
opmental program that results in sporulation. They also pro-
duce a wide variety of antibiotics with important uses in med-
icine and in agriculture. These antibiotics are the products of
complex biosynthetic pathways, activated typically in a growth
phase-dependent manner (3). In liquid culture, antibiotic pro-
duction generally occurs in stationary phase (4, 5), while in
surface-grown cultures, it usually coincides with the onset of
morphological differentiation, i.e. the formation of aerial
hyphae.
The most intensively studied g-butyrolactone is A-factor (2-
isocapryloyl-3R-hydroxymethyl-g-butyrolactone), which is re-
quired for streptomycin production and sporulation in Strepto-
myces griseus (6). A-factor binds to a cytoplasmic protein that
in its absence represses streptomycin production and morpho-
logical differentiation (7). Other g-butyrolactones have also
been shown to induce antibiotic biosynthesis, e.g. the virginiae
butanolides of Streptomyces virginiae (8, 9). Moreover, since at
least 60% of Streptomyces species appear to produce g-butyro-
lactones (9), these compounds are likely to play important roles
as extracellular signaling molecules in the biology of these
organisms. Streptomyces coelicolor A3(2), the most genetically
characterized streptomycete, produces at least four antibiotics,
including the blue-pigmented polyketide actinorhodin (Act),1
and the red-pigmented tri-pyrolle undecylprodigiosin (Red),
both of which are produced in a growth phase-dependent man-
ner (4, 5, 10). Earlier studies (11, 12) led to the isolation and
partial structural determination of six g-butyrolactones made
by S. coelicolor (Fig. 2), but there was no report of their biolog-
ical activity in the producing strain.
This paper identifies four low molecular weight compounds
present in the supernatants of transition and stationary phase
cultures of S. coelicolor that can elicit the precocious production
of Act and Red when added exogenously to the strain. One of
the compounds, SCB1, was purified and its structure
((2R,3R,19R)-2-(19-hydroxy-6-methylheptyl)-3-hydroxymethyl-
butanolide) determined using electron impact mass spectrom-
etry (EI-MS), infrared (IR) spectroscopy, nuclear magnetic res-
onance (NMR), and circular dichroism (CD).
EXPERIMENTAL PROCEDURES
Strains and Media—S. coelicolor M145 (13), and its derivatives
M510 (DredD) and M511 (DactII-ORF4) (14), were manipulated as
described previously (13). SMM (as in Ref. 5, but with no NH4(SO4)2 and
with phosphate levels reduced to 0.25 mM NaH2PO4, 0.25 mM K2HPO4),
YEME (13), and TSB (13) were used to grow M145 for g-butyrolactone
synthesis, and SMMS (14), MM (13), R2 (13), and R2YE (13) were used
to assay for antibiotic production.
Bioassay—Confluent lawns of S. coelicolor spores were spread on
SMMS plates and allowed to dry. For most assays, 6- or 11-mm diam-
eter holes were made in the agar with a cork-borer, and the bottoms of
the holes sealed with 1% agar. Samples in methanol (diluted with an
equal volume of 50 mM Tris-HCl, pH 7.2, 1 mM EDTA) or culture
supernatants (up to 200 ml) were pipetted into the holes, and the plates
incubated at 30 °C for 30–37 h. For some assays, samples were applied
directly to the lawn of spores. To determine the minimum concentration
of SCB1 required for precocious antibiotic production, the chemically
synthesized compound was added to 8 ml of SMMS agar at varying
concentrations, and the agar poured into 9-cm diameter Petri dishes.
Confluent lawns of M145 spores were added, and the plates incubated
at 30 °C for 30–37 h.
Heat and Protease Treatment—Culture supernatants were boiled for
30 min or incubated at 80 °C for 1 h. Protease K, Pronase, and trypsin
(all from Sigma) were incubated with culture supernatants at 37 °C for
1 h. The ability of the treated samples to elicit antibiotic production was
assayed as described above.
Purification of SCB1—Spores of S. coelicolor strain M145 were har-
vested from a MS (formerly known as SFM; Ref. 14) agar plate and used
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to generate a three-stage seed culture. Successive seed cultures were
grown in shake flasks using a 2% (v/v) inoculum. The cultures were
grown at 28 °C and 240 rpm; the primary seed was incubated for 48 h,
and the secondary and tertiary seeds for 24 h. The tertiary seed culture
was used to inoculate (2% v/v) 300 liters of TSB, which was incubated
with pH control at 28 °C for 69 h with an airflow rate of 150 liters
min21, an agitator tip speed of 2 ms21 and an overpressure of 0.5 barg.
Approximately 120 g of wet mycelium liter21 were obtained at harvest.
The pH of the culture supernatant was adjusted from 8.4 to 7.1 with
sulfuric acid, and the resulting 280 liters extracted with 140 liters of
ethyl acetate. The extract was dried with MgSO4 and evaporated to give
24.5 g of oil. The oily sample was resuspended in 100 ml of 100%
methanol and 20 ml were loaded onto a Silica gel 60 extra pure (Merck)
column (bed volume of 230 ml). The sample was eluted with 70% ethyl
acetate, 30% n-hexane, yielding fifteen 50-ml fractions. This procedure
was repeated five times. Each fraction was subjected to the bioassay.
Positive fractions were pooled, filtered through a 0.45-mm cellulose
acetate filter (Sartorious), and evaporated to give 495 mg of oily sample.
Further purifications were all performed with a C18 reverse phase
column (4.6 mm 3 25 cm Spherisorb 5-mm ODS2, Waters) on a Con-
staMetric HPLC equipped with a UV detector (ABI Spectroflow 757) set
at 210 nm, and with a flow rate of 1 ml min21. The oily sample was
resuspended in 90% methanol to give a final volume of 10 ml; 200-ml
aliquots were loaded onto the column and eluted with a linear gradient
of 20% to 100% acetonitrile. Three 7.5-ml fractions were collected and
subjected to the bioassay. This procedure was repeated 50 times, and
the active fractions were pooled and evaporated to give 190 mg of
sample. The material was resuspended in 3 ml of 100% methanol, and
50-ml samples were loaded onto the column and eluted with a linear
gradient of 46.3–49.6% acetonitrile. Nine 1-ml fractions were collected
and evaporated. This procedure was repeated 23 times. Each fraction
was subjected to the bioassay, and the 23 active fractions (one per run)
were loaded separately onto the column and eluted with a linear gra-
dient of 46.3–49.6% acetonitrile containing 0.1% trifluoroacetic acid.
Peaks were collected manually using a chart recorder (BBC Servogor
120) and subjected to the bioassay. The 23 active peaks (one per run)
with the same retention time were pooled and evaporated. The sample
was resuspended in 240 ml of 100% methanol, and 20-ml aliquots were
loaded onto the column and eluted isocratically with 47% acetonitrile
containing 0.1% trifluoroacetic acid. For each of the 12 runs, peaks were
collected manually and assayed for bioactivity. Active peaks with the
same retention time from each of the 12 runs were pooled, evaporated,
and resuspended in 140 ml of 100% methanol. Seven 20-ml aliquots were
loaded onto the column and eluted with a linear gradient of 47–47.5%
acetonitrile containing 0.1% trifluoroacetic acid. Peaks were collected
manually and assayed for bioactivity. Active fractions with the same
retention time were pooled, evaporated, and resuspended in 140 ml of
100% methanol. Seven 20-ml aliquots were loaded onto the column and
eluted isocratically with 42.5% acetonitrile containing 0.1% trifluoro-
acetic acid. Peaks were collected manually from each of the seven runs
and subjected to the bioassay, and single fractions with bioactivity were
evaporated, resuspended in 20 ml of 100% methanol, loaded onto the
column, and eluted with a linear gradient of 20–50% acetonitrile con-
taining 0.1% trifluoroacetic acid. Each peak was collected manually and
subjected to the bioassay. Active peaks with the same retention time
were pooled. Partially purified samples were stored at 4 °C in an evap-
orated state, and the purified sample was stored at 220 °C in 100%
methanol.
Materials for Chemical Synthesis—3-(Hydroxymethyl)butanolide
was made by reduction of diethyl formylsuccinate with NaBH4 and
converted to 3-(trimethysilyloxymethyl)butanolide by trimethylsilyla-
FIG. 1. g-Butyrolactones isolated from streptomycetes, and the antibiotics and developmental events induced by them. The
absolute configurations (2S,3S or 2R,3R) of Factor I and of the three g-butyrolactones made by Streptomyces bikiniensis and Streptomyces
cyaneofuscatus were not determined.
FIG. 2. Structures of the g-butyrolactones isolated previously
from S. coelicolor (from Efremenkova et al. (Ref. 12)).
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tion (15). 1-Bromo-4-methylpentane was purchased from Aldrich.
Analytical Methods—Infrared (IR) spectra were determined as films
on a Horiba model FT-120 Fourier transform-IR spectrophotometer. 1H
NMR spectra were recorded on a Varian model Unity Inova 600 spec-
trometer at 600 MHz using CHCl3 dH 7.25 as an internal reference in
CDCl3 solution. Optical rotation (CD) values were measured on a Jasco
P-1020 polarimeter. Mass spectra were obtained on a Jeol JMS-DX-303
spectrometer.
Physicochemical Data for Natural SCB1—Physicochemical data




, 600 MHz) 4.43 (1H, dd, J 5 9 and 8 Hz, H-4a), 4.03 (1H, ddd,
J 5 9, 5 and 3 Hz, H-19), 3.99 (1H, dd, J 5 9 and 8 Hz, H-4b), 3.77 (1H,
dd, J 5 10 and 5 Hz, H-5a), 3.70 (1H, dd, J 5 10 and 7 Hz, H-5b), 2.79
(1H, m, H-3), 2.66 (1H, dd, J 5 9.5 and 5 Hz, H-2), 1.56 (proton numbers
ambiguous due to overlapping H2O signal, m), 1.33 (3H, m, H-49169),
1.19 (1H, t, J 5 7 Hz, H-59a), 1.18 (1H, t, J 5 7 Hz, H-59b), 0.87 (6H, d,
J 5 7 Hz, H-79189).
Chiral Synthesis of the SCB1 Stereoisomers—For diethyl 2-(49-meth-
ylpentyl)malonate (Fig. 3, 1), sodium (1.65 g) was added to 40 ml of
absolute ethanol, and the mixture stirred at 55 °C until no sodium was
visible. After cooling the mixture to ,50 °C, diethyl malonate (12.4 g)
was added dropwise and refluxed for 20 min. 1-Bromo-4-methylpentane
(11.64 g) was added dropwise to the solution with stirring. After reflux-
ing for 2 h, the reaction mixture was evaporated to remove ethanol,
acidified with 3 N HCl, and extracted with CH2Cl2. The CH2Cl2 layer
was dried over anhydrous Na2SO4, and evaporated to yield 16.1 g of
crude 1. For 2-(49-methylpentyl)malonic acid (Fig. 3, 2), crude 1 (11 g)
was mixed with KOH solution (11 g in 35 ml of water and 80 ml of
methanol) and left overnight at room temperature with stirring. The
reaction mixture was evaporated to remove methanol, acidified with 3
N HCl, and extracted with CH2Cl2. After drying over anhydrous
Na2SO4, the CH2Cl2 layer was evaporated to yield white crystals of 2
(8.2 g, yield 96%). For 6-methylheptanoic acid (Fig. 3, 3), the white
crystals of 2 (8.1 g) were heated at 145 °C in the presence of boiling
stones for 8 h. 10% NaHCO3 solution (200 ml) was added, and the
mixture extracted once with hexane to remove neutral impurities. The
water layer was acidified with 3 N HCl, followed by CH2Cl2 extraction.
The CH2Cl2 layer was dried, evaporated, and the residue was purified
by distillation yielding 3.7 g of 3 (yield 60%).
Physicochemical data for 3 are as follows: EI-MS m/z 145 (M1H)1,
127 (M1H-H2O)
1; 1 H NMR d (CDCl 3, 400 MHz) 2.32 (2H, dd, J 5 8
and 7 Hz, CH2-COOH), 1.59 [2H, dt, J 5 15 and 7 Hz, (CH3)2CH-CH2],
1.51 [1H, m, (CH3)2CH], 1.31 (2H, m, -CH2-), 1.17 (1H, t, J 5 6 Hz,
-CH2-CH2-COOH), 1.15 (1H, t, J 5 7 Hz, -CH2-CH2-COOH), 0.84 [6H, d,
J-7 Hz, (CH3)2-CH]; IR (film) 3037 and 1713 cm
21.
Racemic A-factor (Fig. 3, 4) (0.7 g, yield 52%) was synthesized by
reacting 3-(trimethyl-silyloxymethyl)butanolide (1.03 g) with 6-methyl-
heptanoic acid chloride (0.99 g) in the presence of lithium diisopro-
pylamine in dry tetrahydrofuran under N2 (15). 6-Methylheptanoic acid
chloride was prepared from 3 with oxalyl chloride. Physicochemical
data were identical to those reported (16).
Racemic IM-2-type and VB-type SCB1—Racemic A-factor (100 mg in
5 ml of ethanol) was reduced with 1.1 eq of NaBH4 at 4 °C. The reaction
was terminated by adding 3 N HCl, and the solution extracted with
ethyl acetate. The extract was evaporated, and the residue purified by
C18 reverse-phase HPLC (Capcell Pak C18, 4.6 3 250-mm column (Shi-
seido Co. Ltd., Kyoto, Japan), with 35% acetonitrile containing 0.1%
trifluoroacetic acid as solvent at a flow rate of 1.5 ml min21 and with
detection at 210 nm) to give racemic VB-type SCB1 (retention time 20.1
min, 20% yield) and IM-2-type SCB1 (retention time 22.8 min, 45%
yield).
Chiral HPLC—Racemic VB-type SCB1 was separated into two en-
antiomers by chiral HPLC (Chiralpak AD, 4.6 3 250 mm column
(Daicel Co. Ltd., Tokyo, Japan) with hexane:ethanol (92:8) as solvent at
a flow rate of 1.1 ml min21, and with detection at 210 nm) to give
(2R,3R,19S)-SCB1 (retention time 25.5 min, 26% yield) and (2S,3S,19R)-
SCB1 (retention time 15.4 min, 26% yield). Racemic IM-2-type SCB1
was separated similarly (at a flow rate of 0.75 ml min21) to give
(2R,3R,19R)-SCB1 (retention time 25.1 min, 26% yield) and (2S,3S,19S)-
SCB1 (retention time 28.4 min, 24% yield).
Physicochemical data for synthetic (2R,3R,19R)-(-)-SCB1 (Fig. 3, 5)
were as follows: [a]D
23 5 220.3° (c. 0.065, CHCl3); IR (film) 1755 cm
21;
EI-MS m/z 245 (M1H)1, 226 (M1H-H2O)
1; 1H NMR d (CDCl3, 600
MHz) 4.43 (1H, dd, J 5 9 and 8 Hz, H-4a), 4.03 (1H, ddd, J 5 9, 5 and
3 Hz, H-19), 3.99 (1H, dd, J 5 9 and 8 Hz, H-4b), 3.77 (1H, dd, J 5 10
and 5 Hz, H-5a), 3.70 (1H, dd, J 5 10 and 7 Hz, H-5b), 2.79 (1H, m, H-3),
2.66 (1H, dd, J 5 9.5 and 5 Hz, H-2), 1.56 (4H, m, H-29139), 1.34 (3H,
m, H-49169), 1.19 (1H, t, J 5 7 Hz, H-59a), 1.18 (1H, t, J 5 7 Hz, H-59b),
0.87 (6H, d, J 5 7 Hz, H-79189).
Physicochemical data for synthetic (2S,3S,19S)-(1)-SCB1 (Fig. 3, 6)
were as follows: [a]D
23 5 116.5° (c. 0.06, CHCl3);
1H NMR, EI-MS, and
IR data were identical to those for (2R,3R,19R)-(2)-SCB1.
Physicochemical data for synthetic (2R,3R,19S)-SCB1 (Fig. 3, 7):
[a]D
235 -32.8° (c. 0.065, CHCl3); EI-MS m/z 245 (M1H)
1, 226 (M1H-
H2O)
1; IR (film) 1749 cm21; 1H NMR d (CDCl3, 600 MHz) 4.40 (1H, dd,
J 5 9 and 8 Hz, H-4a), 4.11 (1H, m, H-19), 4.08 (1H, dd, J 5 9 and 8 Hz,
FIG. 3. Chemical synthesis of SCB1.
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H-4b), 3.74 (1H, dd, J 5 10 and 5 Hz, H-5a), 3.70 (1H, dd, J 5 10 and
6 Hz, H-5b), 2.84 (1H, m, H-3), 2.55 (1H, dd, J 5 7.1 and 4 Hz, H-2), 1.53
(4H, m, H-29139), 1.28 (3H, m, H-49169), 1.16 (2H, ddt, J 5 14, 7 and 2
Hz, H-59), 0.85 (6H, d, J 5 7 Hz, H-79189).
Physicochemical data for synthetic (2S,3S,19R)-SCB1 (Fig. 3, 8) were
as follows: [a]D
23 5 128.2° (c. 0.065, CHCl3);
1H NMR, EI-MS, and IR
data were identical to those for (2R,3R,19S)-SCB1.
RESULTS
Transition and Stationary Phase Culture Supernatants of S.
coelicolor Elicit Precocious Antibiotic Production—Exponential
phase (A450 5 0.4), late exponential phase (A450 5 0.7), early
transition phase (A450 5 1.0), late transition phase (A450 5 1.5),
and stationary phase (A450 5 2.0) culture supernatants of S.
coelicolor M145 grown in SMM were assayed for their ability to
elicit precocious production of the pigmented antibiotics Act
and Red in lawns of the same strain grown on SMMS. While
supernatants from exponential and early transition phase cul-
tures showed no activity, those from late transition phase and
stationary phase cultures appeared to elicit production of both
antibiotics (Fig. 4A). Exponential phase culture supernatants
concentrated 50-fold by freeze-drying failed to show activity.
Essentially the same results were obtained when M145 was
grown in complex YEME and TSB liquid media, and when MM,
R2, and R2YE rather than SMMS were used to assay for
precocious antibiotic production. The ability of the culture su-
pernatants to cause premature Act and Red production on
several defined and complex media suggests that the activity of
the factor(s) responsible is not highly dependent on the nutri-
tional state of the culture, and is consistent with a key role for
the factor(s) in determining the onset of antibiotic production.
To establish unambiguously that the observed pigment produc-
tion reflected synthesis of both of the colored antibiotics, mu-
tants carrying deletions in one or other of the pathway-specific
activator genes for Act (actII-ORF4) and Red (redD) synthesis,
M511 and M510, respectively, were used as lawns in the bio-
assay. The late transition and stationary phase culture super-
natants stimulated the production of Act in M510 and Red in
M511 (Fig. 4B), confirming the induced synthesis of both of the
pigmented antibiotics. Interestingly, the stimulatory effect was
only observed when the culture supernatants were added
within 8 h of spreading the lawns of M145, M510, or M511
spores; later addition had no effect.
Stimulation of Antibiotic Production Is Caused by Small
Diffusible Factors—When a stationary phase culture superna-
tant of M145 that possessed stimulatory activity was dialyzed
against 50 mM Tris-HCl, pH 7.2, 1 mM EDTA, all activity was
lost. Use of a Centricon-3 (Amicon) filter indicated that the
molecular weight of the active factor(s) was less than 3000. The
stimulatory activity was resistant to protease and heat treat-
ment (100 °C for 30 min and 80 °C for 1 h); it was stable in
acidic conditions (pH1.0 for 30 min), unstable in alkali (pH12.0
for 10 min), and was readily extracted into ethyl acetate and
chloroform. Moreover, C18 reverse phase HPLC using an ace-
tonitrile/water mobile phase gave a peak with bioactivity that
eluted at approximately 50% acetonitrile. All of these proper-
ties are characteristics associated with g-butyrolactones.
Purification of the Major Stimulatory Factor Made by S.
coelicolor—A 300-liter culture of S. coelicolor M145 was grown
in TSB at 28 °C for 69 h, and the supernatant extracted with
ethyl acetate at neutral pH. After evaporation, the oily extract
was passed through a silica gel column using 70% ethyl ace-
tate, 30% n-hexane as solvent, and fractions with stimulatory
activity were obtained. Further purification was achieved by
C18 reverse phase HPLC using an acetonitrile gradient as
mobile phase. To maximize the separation of individual peaks,
an analytical column was used throughout the remainder of the
purification. Two rounds of C18 reverse phase HPLC yielded
two peaks with bioactivity. The major peak eluted at 47.0%
acetonitrile, and the minor peak at 48.2%. The minor peak was
later shown to contain at least two stimulatory activities. Fur-
ther purification was performed only with the major peak. Six
additional rounds of C18 reverse phase HPLC gave a single
peak with stimulatory activity, which was designated SCB1. A
small peak with stimulatory activity that had a retention time
just slightly longer than that of SCB1 (10.8 min versus 9.9 min
on 42.5% acetonitrile isocratic elution) was also identified, but
there was too little material for structural determination.
FIG. 4. Bioassay of culture supernatants of S. coelicolor M145.
A, ethyl acetate extracts (1 ml) of supernatants of late exponential and
late transition phase cultures were spotted (X) on a SMMS plate seeded
with a confluent lawn of M145 spores. B, stationary phase culture
supernatants were placed in wells (200 ml in the top wells and 50 ml in
the bottom wells) made in an agar plate that had been spread with a
confluent lawn of spores of S. coelicolor M145 (top), M511 (DactII-ORF4)
(bottom left), and M510 (DredD) (bottom right). Plates were incubated at
30 °C for 30–37 h.
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Thus, S. coelicolor produces at least four compounds that can
induce precocious antibiotic production.
Structure of SCB1—One-dimensional 600-MHz 1H NMR
(Fig. 5) indicated that the purified compound possessed a typ-
ical 2,3-disubstituted g-butyrolactone skeleton, as evident from
the signals at 4.43, 4.03, 3.99, 3.77, 3.70, 2.79, and 2.66 ppm.
The signals at 4.43 and 3.99 ppm correspond to methylene
protons at C-4 (Fig. 3, 5), and those at 3.77 and 3.70 ppm to
hydroxymethylene protons at C-5. The signals at 4.03, 2.79,
and 2.66 ppm correspond to three methine protons at C-19, C-3,
and C-2, respectively. The remaining signals at 1.56, 1.33 (3
protons), 1.19 (2 protons), and 0.87 ppm (6 protons) appeared to
originate from an alkyl side chain at C-2, although the broad
signal of contaminating H2O at 1.7 ppm overlapped the 1.56
ppm signal, preventing determination of the number of protons
in the 1.56 ppm signal. However, the doublet signal at 0.87 ppm
corresponds to six protons of two methyl groups and indicated
the presence of a terminal isopropyl moiety. Supposing that
two to four methylene protons in the 1.56 ppm signal were
masked by the 1.7 ppm H2O signal, the structure of the C-2 side
chain could be either 19-hydroxy-59-methylhexyl (n 5 2) or
19-hydroxy-69-methylheptyl (n 5 3). To confirm these predic-
tions, a two-dimensional H-H COSY spectrum of SCB1 was
determined (Fig. 6). All of the expected couplings were
observed.
H-4b (3.99 ppm)3 H-4a (4.43)
2
H-3 ~2.79 ppm! 3 H-5a1b ~3.77 and 3.70 ppm!
2
H-2 (2.66 ppm)3 H-19 (4.03 ppm)3 H-29 (1.56 ppm)
SCHEME 1
Several attempts to eliminate contaminating water from the
sample were unsuccessful, reflecting the limiting amount of
purified compound (;320 mg) available; this prevented deter-
mination of the number of methylenes between C-19 and the
terminal isopropyl moiety by 1H NMR. However, EI-MS of the
purified compound gave a clear parent signal of m/z 245
(M1H)1, indicating that SCB1 has a 19-hydroxy-69-methylhep-
tyl group at C-2, and a molecular weight of 244.
The coupling constant between H-2 and H-3 (J2,359.5 Hz)
was different from that of VB-A (J2,357.4 Hz) (17), but agreed
well with that of IM-2 (J2,359.3 Hz) (18), suggesting that SCB1
possesses an IM-2-type stereochemistry about C-2, 3 and 19. To
confirm the IM-2-type nature of SCB1, the retention time of the
purified compound upon C18 reverse phase HPLC was com-
pared with those of synthetic IM-2-type and VB-type g-butyro-
lactones. Samples were prepared by NaBH4 reduction of syn-
thetic A-factor followed by purification on reverse-phase HPLC.
Natural SCB1 and the IM-2-type reduced A-factor derivative
eluted at 11.8 min, while the VB-type reduced A-factor eluted
at 10.2 min, indicating that natural SCB1 has an IM-2-like
stereochemistry, either 2R,3R,19R or the enantiomeric
2S,3S,19S.
Chemical Synthesis of SCB1 and Its Stereoisomers—To de-
termine the absolute configuration of SCB1, the IM-2-type
enantiomers (2R,3R,19R and 2S,3S,19S) and the VB-type enan-
tiomers (2R,3R,19S and 2S,3S,19R) of SCB1 were chemically
synthesized (Fig. 3). Racemic A-factor was synthesized by acy-
lating 3-(trimethylsilyloxymethyl)butanolide with 6-methyl-
heptanoic acid chloride. Reduction with NaBH4 and separation
by C18 reverse-phase HPLC gave racemic mixtures of the IM-
2-type and VB-type compounds. Separation of each racemic
mixture by chiral HPLC yielded optically pure compounds.
Since natural VB-A and IM-2 possess negative optical rotations
(CD-) and their absolute configurations had been determined
unambiguously to be 2R,3R (19), each of the chemically syn-
thesized stereoisomers that possessed a negative optical rota-
tion was assigned as 2R,3R. The elution time of natural SCB1
from a Chiralpak AD column using hexane:ethanol (92:8) as
mobile phase at a flow rate of 0.5 ml min21 was 33.3 min,
identical to that of the synthetic 2R,3R,19R isomer, whereas the
2S,3S,19S isomer eluted after 30.4 min. Consequently, the
structure of natural SCB1 was deduced to be (2R,3R,19R)-2-(19-
hydroxy-6-methylheptyl)-3-hydroxymethylbutanolide (Fig. 3).
Minimum Concentration of SCB1, Its Stereoisomers, and
Other g-Butyrolactones Required to Elicit Precocious Antibiotic
FIG. 5. 600-MHz 1H NMR spectrum of SCB1. The predicted plain structure of SCB1 is shown in the inset. The number above each signal
indicates the corresponding proton in SCB1.
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Production in S. coelicolor—The minimum concentration of
each of the four stereoisomers of SCB1 needed to induce anti-
biotic production in the SMMS plate bioassay was determined
to be: SCB1 (2R,3R,19R), between 128 and 256 nM (Fig. 7);
(2S,3S,19S), 410 and 4100 nM; (2R,3R,19S), 410 and 4100 nM;
(2S,3S,19R), 780 and 7800 nM. The concentration of SCB1 re-
quired to elicit antibiotic production in S. coelicolor appears to
be considerably higher than the levels of A-factor (about 1 nM;
Ref. 20) and virginiae butanolides (about 3 nM; Ref. 21) re-
quired to induce antibiotic production in S. griseus and S.
virginiae, respectively, but corresponds to the level of stimula-
tory activity observed on bioassay of transition and stationary
phase supernatants of SMM-grown cultures (the zones of anti-
biotic production indicated stimulatory activity equivalent to
approximately 250 nM SCB1). Interestingly, high concentra-
tions of SCB1 (.1,000 nM) inhibited Act and Red production in
S. coelicolor (Fig. 7), but had no inhibitory effect on growth or
morphological differentiation. An inhibitory effect was also ob-
served for high concentrations (.1, 400 nM) of racemic VB-C on
virginiamycin production in S. virginiae,2 and for high concen-
trations of A-factor (410–4100 nM) on the formation of aerial
mycelium in S. griseus (Ref. 11; the effect on streptomycin
production was not reported). Both A-factor and a C5 derivative
of IM-2 elicited precocious antibiotic production in S. coelicolor
at concentrations of 26,000 and 495,000 nM, respectively, far
higher than those required for SCB1 (,256 nM), while VB-C
was inactive at a concentration of 440,000 nM.
DISCUSSION
A g-butyrolactone, SCB1, with the ability to induce the pre-
cocious production of both Act and Red in S. coelicolor, was
purified to homogeneity and its structure determined. SCB1
does not correspond to any of the six g-butyrolactones reported
to be made by S. coelicolor (12) (Fig. 2). The biological activity
of these compounds in S. coelicolor was not described, although
they restored streptomycin production and sporulation to an
A-factor-deficient mutant of S. griseus, albeit at a 500-fold
higher concentration than A-factor itself. Whether SCB1 also
has this activity remains to be determined. SCB1 may be iden-
tical to factor I, a g-butyrolactone made by Streptomyces viri-
dochromogenes (22) (Fig. 1); while the C2, C3 positions of
Factor I were defined as trans (i.e. 2S,3S or 2R,3R), and the
configuration of the hydroxyl at C19 as b (23), as in SCB1, the
absolute configuration of the molecule was not determined.
While this compound was able to induce leucomycin production
and aerial mycelium formation in S. griseus ZIMET 43682, its
role in the producing organism was not reported. Recently,
g-butyrolactone-like compounds were identified in S. coelicolor
that were able to elicit precocious morphological differentiation
(21) but not antibiotic production2 in the producing strain, the
converse of the phenotypes associated with SCB1. It thus ap-
pears that S. coelicolor produces several different g-butyrolac-2 T. Nihira, unpublished data.
FIG. 6. Two-dimensional H-H COSY spectrum of SCB1. The numbers adjacent to the signals indicate the cross-peaks between the
corresponding protons in SCB1 (see Fig. 5).
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tones with distinct biological activities.
Each of the three chemically synthesized stereoisomers pos-
sess markedly weaker activities than SCB1, indicating that the
C2, C3, and C19 positions play important roles in determining
the specificity of the g-butyrolactone for its presumed binding
protein. A-factor and IM-2-C5 could both elicit antibiotic pro-
duction in S. coelicolor, but at much higher concentrations than
SCB1. The carbonyl group at the C19 position of A-factor is
susceptible to reduction; consequently, a low level of SCB1
present in the A-factor sample may be responsible for the
relatively high apparent stimulatory activity of A-factor com-
pared with that of IM-2-C5 and VB-C.
In addition to SCB1, three other stimulatory activities were
observed in culture supernatants of S. coelicolor. Two of these
eluted markedly later than SCB1 from the C18 column, and are
likely to be g-butyrolactones with longer carbon side chains
than SCB1. While they may correspond to Acl-1a and Acl-1b
(12) (Fig. 2), since all of the streptomycete g-butyrolactones
whose structures have been absolutely determined possess the
2R,3R configuration, it seems more likely that they correspond
to the 2R,3R diastereomers of these compounds. Interestingly,
the stimulatory effect elicited by addition of culture superna-
tants containing these compounds to lawns of S. coelicolor
spores was only observed if the supernatants were applied
within 8 h of plating out the lawns; later addition had no
stimulatory effect. This is reminiscent of the “decision phase”
described for the effective addition of A-factor to a culture of S.
griseus deficient in A-factor production (12, 24); restoration of
streptomycin production was only observed if A-factor was
added within 10 h of inoculation. It will be interesting to
determine the molecular basis for this apparent growth phase-
dependent response to g-butyrolactone addition.
In S. griseus, only one g-butyrolactone, A-factor, appears to
regulate streptomycin production, and in Streptomyces laven-
dulae, a single g-butyrolactone, IM-2, induces production of the
nucleoside antibiotics showdomycin and minimycin (25). In
contrast, S. virginiae produces at least five virginiae butanol-
ides (VB-A, B, C, D, and E) that stimulate virginiamycin pro-
duction, each with a different minimum effective concentration
(26). Like S. virginiae, S. coelicolor appears to produce several
g-butyrolactones that are capable of stimulating the production
of at least two chemically distinct antibiotics. It will be inter-
esting to determine how these g-butyrolactones elicit their
pleiotropic effect on antibiotic production.
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